The finding that ATF6 silencing inhibits cell-cycle progression and increases CDKi expression in colorectal cancer cells is consistent with recent evidence that ATF6 deletion in pancreatic β-cells during insulitis leads to cell-cycle arrest and increases the expression of CDKN1A (103). Here, ATF6 is linked to colorectal cancer.